E. Horne

发表

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study

Amir, J. Sterne, E. Williamson, 2022, medRxiv.

Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP

M. Hernán, R. Keogh, E. Williamson, 2022, medRxiv.

Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study

A. Mehrkar, B. Goldacre, D. Nitsch, 2022, medRxiv.

Patient characteristics associated with clinically coded long COVID: an OpenSAFELY study using electronic health records

Spiros C. Denaxas, A. Walker, S. Bacon, 2023, medRxiv.

Challenges in estimating waning effectiveness of two doses of BNT162b2 and ChAdOx1 COVID-19 vaccines beyond six months: an OpenSAFELY cohort study using linked electronic health records

R. Keogh, E. Williamson, S. Bacon, 2023, medRxiv.

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records

M. Hernán, J. Sterne, R. Keogh, 2022, medRxiv.

Long-term cardiovascular safety of COVID-19 vaccination according to brand, dose and combinations: Cohort study of 46 million adults in England

F. Torabi, K. Khunti, E. Horne, 2024, medRxiv.